Canonical ingredient
IMIPENEM
15 linked products
Official identifiers
Names and synonyms
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- imipenem hydrate
GLOBAL · CAS 74431-23-5
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
IMIPENEM AND CILASTATIN FOR INJECTION
250 · MG
IMIPENEM AND CILASTATIN FOR INJECTION
500 · MG
IMIPENEM AND CILASTATIN FOR INJECTION USP
250 · MG · VIAL
IMIPENEM AND CILASTATIN FOR INJECTION USP
500 · MG · VIAL
IMIPENEM AND CILASTATIN FOR INJECTION, USP
250 · MG · VIAL
IMIPENEM AND CILASTATIN FOR INJECTION, USP
500 · MG · VIAL
IMIPENEM AND CILASTATIN FOR INJECTION, USP
250 · MG · VIAL
IMIPENEM AND CILASTATIN FOR INJECTION, USP
500 · MG · VIAL
PRIMAXIN 250
250 · MG · VIAL
PRIMAXIN 500
500 · MG · VIAL
PRIMAXIN IV 250/250 ADD-VANTAGE VIAL
250 · MG · VIAL
PRIMAXIN IV 500
500 · MG · VIAL
RECARBRIO
500 · MG · VIAL
TARO-IMIPENEM-CILASTATIN
250 · MG · VIAL
TARO-IMIPENEM-CILASTATIN
500 · MG · VIAL